Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Background: Biliary tract carcinoma (BTC) is cancer of the slender tubes that carry fluids in the liver. People with advanced BTC have few treatment options, …

Biliary CancerBile Duct CancerCancer of the Bile Duct

National Cancer Institute (NCI)NCT05849480